Behavioral and Social Research Funding Opportunities and Applicant Resources

Time-Limited Funding Opportunities
BSR Opportunities in AD/ADRD
Current Funding Opportunities
Research and Funding FAQs

Time-Limited Funding Opportunities

Time-limited NOFOs typically have a single due date and a special allocation of funds. BSR is accepting grant applications to a number of time-limited funding opportunities in different scientific domains related to aging, AD/ADRD, and COVID-19 research. Please see below for current time-limited funding opportunities.

NOFO Number	Title	Focus	Release Date	Final Due Date
RFA-AG-24-034	High-Priority Behavioral and Social Research Networks  (R24 Clinical Trial Optional) NIA intends to commit $2,000,000 in fiscal year 2024 to fund up to 6 awards.	Aging	9/5/2023	11/1/2023
RFA-AG-24-033	State Dementia Care Research Center (U54 Clinical Trial Not Allowed) NIA intends to commit $4,000,000 in fiscal year 2024 to fund 1 award.	AD/ADRD	9/6/2023	11/14/2023
RFA-AG-24-031	Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional) NIA intends to commit $3,000,000 in fiscal year 2024 to fund 4-5 awards.	AD/ADRD	8/28/2023	10/30/2023
RFA-AG-24-030	Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional) NIA intends to commit $3,000,000 in fiscal year 2024 to fund 1 award.	AD/ADRD	8/28/2023	10/30/2023
RFA-AG-24-029	Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD (R21 Clinical Trial Not Allowed) NIA intends to commit $1,000,000 in fiscal year 2024 to fund 6 awards.	AD/ADRD Aging	8/9/2023	11/3/2023
RFA-AG-24-028	Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD (R01 Clinical Trial Not Allowed) NIA intends to commit $3,000,000 in fiscal year 2024 to fund 6 awards.	AD/ADRD Aging	8/9/2023	11/3/2023
RFA-AG-24-050	Health Equity and the Cost of Novel Treatments for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed) NIA intends to commit $1.2 million in fiscal year 2024 to fund 4 awards.	AD/ADRD	7/19/2023	10/31/2023
RFA-AG-24-048	Primary Care-Based Screening Tool and Intervention Development for the Detection and Prevention of Abuse and Neglect in Older and Vulnerable Adults With, or at Risk for, Mild Cognitive Impairment and AD/ADRD (R61/R33 Clinical Trial Required) For the R61 phase, and pending annual appropriations, NIA intends to commit $3.21 million in fiscal year 2024 to fund 2-4 R61 awards. For the R33 phase, and pending annual appropriations, NIA intends to commit $5.6 million in fiscal years 2026, 2027, and 2028 to fund 2-4 R33 awards.	AD/ADRD	7/6/2023	10/20/2023
RFA-AG-24-026	Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional) NIA intends to commit $1,500,000 in fiscal year 2024 and expects to fund 3-5 awards. Applicant Resources for the Leveraging Social Networks to Promote Widespread Individual Behavior Change RFAs	Aging	6/8/2023	11/3/2023
RFA-AG-24-025	Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional) NIA intends to commit $2,000,000 in fiscal year 2024 and expects to fund 3-4 awards. Applicant Resources for the Leveraging Social Networks to Promote Widespread Individual Behavior Change RFAs	Aging	6/8/2023	11/3/2023
RFA-AG-24-032	Enhancing Use of Harmonized Cognitive Assessment Protocol Data (R01 Clinical Trial Not Allowed) NIA intends to commit $3,500,000 in fiscal year 2024 to fund 4-5 awards	Aging AD/ADRD	5/31/2023	10/2/2023
RFA-AG-24-036	Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)  NIA intends to commit $3,000,000 in fiscal year 2024 to fund 6 awards. Applicant Resources for the Measuring Financial Hardship Among People and Families Living with AD/ADRD RFA	AD/ADRD	5/17/2023	10/23/2023
RFA-AG-24-011	Research Coordinating Center on the Exposome and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD): Elucidating the Role of Social and Behavioral Determinants of Health in AD/ADRD Etiology and Disparities (U24 Clinical Trial Not Allowed) NIA intends to commit $5,000,000 in FY 2024 to fund 1 award. Applicant Resources for the Research Coordinating Center on the Exposome and AD/ADRD RFA	AD/ADRD	2/9/2023	10/27/2023

BSR Opportunities in AD/ADRD

Parent Funding Opportunities and Associated NOSIs

NIA has two parent funding opportunities that invite applications on a variety of Alzheimer’s disease and Alzheimer's disease related dementias research topics. PAR-22-093 is for R01 applications and PAR-22-094 is for R21 applications. Notices of Special Interest associated with these parent NOFOs specify high priority behavioral and social research topics and are listed below.

NOFO Number	Title	Release Date	Expiration Date
NOT-AG-21-051	Notice of Special Interest (NOSI): Sleep Disorders and Circadian Clock Disruption in Alzheimer's Disease and other Dementias of Aging	1/11/2022	11/13/2024
NOT-AG-21-050	Notice of Special Interest (NOSI): Sex and Gender Differences in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD)	1/6/2022	11/13/2024
NOT-AG-21-049	Notice of Special Interest (NOSI): Dementia Care Workforce for Those Living with Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD)	1/6/2022	11/13/2024
NOT-AG-21-048	Notice of Special Interest (NOSI): Digital Technology for Early Detection and Monitoring of Alzheimer’s Disease and Related Dementias	1/6/2022	11/13/2024
NOT-AG-21-047	Notice of Special Interest (NOSI): Behavioral and Social Science Priority Areas in Dementia Care Partner/Caregiver Research	1/6/2022	11/13/2024
NOT-AG-21-046	Notice of Special Interest (NOSI): Dementia Care Research: Programs and services for persons with dementia	1/6/2022	11/13/2024
NOT-AG-21-045	Notice of Special Interest (NOSI): Opportunities for Research in Epidemiology of Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) and Cognitive Resilience	1/6/2022	11/13/2024
NOT-AG-21-044	Notice of Special Interest (NOSI): Sensory and Motor System Changes as Predictors of Preclinical Alzheimer's Disease	1/6/2022	11/13/2024
NOT-AG-21-039	Notice of Special Interest: Understanding Alzheimer's Disease in the Context of the Aging Brain	12/30/2021	11/13/2024
NOT-AG-21-036	Notice of Special Interest (NOSI): Novel Approaches to Diagnosing and Studying Clinical Alzheimer's Disease and Related Dementias	1/7/2022	11/13/2024
NOT-AG-21-035	Notice of Special Interest: Collaborative Studies on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD)	12/30/2021	11/13/2024
NOT-AG-21-033	Notice of Special Interest: Health Disparities and Alzheimer's Disease	12/22/2021	11/13/2024

Major Opportunities in AD/ADRD Research

In addition to the parent AD/ADRD funding opportunities, BSR participates in other announcements aimed specifically at building AD/ADRD research infrastructure, developing clinical trials, and more. AD/ADRD research is also included in many other announcements in which BSR participates, detailed in the Current Funding Opportunities section below.

NOFO Number	Title	Release Date	Expiration Date
PAR-21-360	Pilot Studies for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)	1/10/2022	1/8/2025
PAR-21-359	Early and Late Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)	1/10/2022	1/8/2025
PAR-22-362	NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)	1/7/2022	10/2/2024
PAR-22-077	NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional)	12/22/2021	10/18/2024
PAR-21-307	Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) Frequently Asked Questions for PAR-21-307	8/11/2021	2/14/2024
PAR-21-308	Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 – Clinical Trial Required)	8/11/2021	2/14/2024
PAR-21-220	NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed)	5/28/2021	6/13/2024
PAR-21-218	NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31)	5/28/2021	8/9/2024
PAR-21-217	NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)	5/28/2021	8/9/2024
PAR-21-112	Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)	1/22/2021	9/26/2023

Current Funding Opportunities

BSR is accepting grant applications to a number of funding opportunities in different scientific domains related to aging, AD/ADRD, and COVID-19 research. Please see below for current funding opportunities.

The full list of NIA-wide active funding opportunities and NIA-wide AD/ADRD funding opportunities can also be found online.

NOFO Number	Title	Focus	Release Date	Expiration Date
NOT-AG-23-015	Notice of Special Interest (NOSI): Alzheimer’s-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimer’s Disease	AD/ADRD	5/4/2023	10/3/2023
PAR-23-179	Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)	Aging	4/24/2023	3/17/2026
NOT-AG-23-021	Notice of Participation of the National Institute on Aging (NIA) in PAR-22-181, "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"	Aging	4/21/2023	9/8/2025
PAR-23-144	STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)	Aging	4/20/2023	9/19/2025
NOT-OD-22-203	Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions	Aging	9/9/2022	9/27/2024
NOT-OD-22-166	Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People	AD/ADRD Aging	8/11/2022	5/8/2025
NOT-MD-22-012	Notice of Special Interest (NOSI): Research on the Health of Sexual and Gender Minority (SGM) Populations	AD/ADRD Aging	7/11/2022	8/8/2025
NOT-OD-22-167	Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes	AD/ADRD Aging	7/8/2022	10/5/2025
PAR-22-213	Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)	AD/ADRD Aging	7/7/2022	9/26/2025
NOT-ES-22-006	Notice of Special Interest (NOSI): Climate Change and Health	AD/ADRD Aging	6/1/2022	5/8/2025
PAR-22-105	Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)	AD/ADRD Aging	5/10/2022	5/8/2025
PAR-22-109	Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)	AD/ADRD Aging	5/10/2022	5/8/2025
PAR-22-106	Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)	AD/ADRD Aging	5/9/2022	9/8/2025
RFA-AG-23-016	Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)	AD/ADRD Aging	4/11/2022	10/19/2024
PAR-22-145	Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)	AD/ADRD Aging	3/31/2022	5/8/2025
PAR-22-072	Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)	AD/ADRD Aging	11/22/2021	5/8/2024
PAR-22-060	Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)	AD/ADRD Aging	1/10/2022	1/8/2025
NOT-AG-22-004	Notice of Special Interest: Research on Pain, Pain Management, and Opioids in Aging	AD/ADRD Aging	12/22/2021	1/8/2025
PAR-21-352	Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trial Required)	AD/ADRD Aging	10/5/2021	9/8/2024
PAR-21-350	Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)	AD/ADRD Aging	10/5/2021	6/22/2024
PAR-21-349	Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)	AD/ADRD Aging	10/5/2021	6/22/2024
NOT-MH-21-330	Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations	COVID-19	8/20/2021	9/8/2024
PAR-21-275	The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)	AD/ADRD Aging	6/25/2021	9/8/2024
PAR-21-154	Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)	AD/ADRD Aging	5/19/2021	5/8/2024
NOT-OD-21-100	Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health	AD/ADRD Aging	4/8/2021	6/8/2024
NOT-AT-21-002	Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease	AD/ADRD Aging	1/22/2021	5/7/2024
NOT-AG-21-012	Notice of Special Interest: Integrative Studies of Neural Mechanisms Underlying Fundamental Affective Processes in Aging	AD/ADRD Aging	10/15/2020	1/8/2024

Research & Funding FAQs

Access frequently asked questions related to NIA research and funding.